Literature DB >> 8013960

A novel monoclonal antibody recognizing human thymocytes and B-cell chronic lymphocytic leukemia cells.

P Tassone1, P Bonelli, F Tuccillo, H M Bond, M C Turco, G Morrone, L Cecco, M Cerra, S Venuta.   

Abstract

This paper describes a new murine monoclonal antibody, UN5, raised against human thymocytes. This antibody recognizes a molecule of approximately 45 kDa on thymocytes. Flow cytometric analysis reveals a high intensity of labeling with the majority of thymocytes, whereas only CD20+ cells from peripheral whole-blood samples are weakly stained. Peripheral T cells, granulocytes, platelets and red blood cells do not express this antigen, while monocytes are only weakly labeled by UN5. Furthermore, the UN5 antibody discriminates between different types of B-cell malignancies, reacting with a subgroup of B-cell chronic lymphocytic leukemias and hairy cell leukemias, but not with the other kinds of hematopoietic malignancies tested. Antibody UN5 should prove a useful tool for the study of T-cell precursors and for analysis of both normal and neoplastic B cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013960     DOI: 10.1016/0165-2478(94)90098-1

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  1 in total

1.  A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells.

Authors:  Caterina Riillo; Daniele Caracciolo; Katia Grillone; Nicoletta Polerà; Franca Maria Tuccillo; Patrizia Bonelli; Giada Juli; Serena Ascrizzi; Francesca Scionti; Mariamena Arbitrio; Mariangela Lopreiato; Maria Anna Siciliano; Simona Sestito; Gabriella Talarico; Eulalia Galea; Maria Concetta Galati; Licia Pensabene; Giovanni Loprete; Marco Rossi; Andrea Ballerini; Massimo Gentile; Domenico Britti; Maria Teresa Di Martino; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.